Your browser doesn't support javascript.
loading
Increased levels of tissue factor pathway inhibitor may reflect disease activity and play a role in thrombotic tendency in Behçet's disease.
Akarsu, M; Demirkan, F; Ozsan, G H; Onen, F; Yüksel, F; Ozkan, S; Undar, B.
Affiliation
  • Akarsu M; Department of Medicine, Division of Hematology/Oncology, Dokuz Eylül University School of Medicine, Izmir, Turkey.
Am J Hematol ; 68(4): 225-30, 2001 Dec.
Article in En | MEDLINE | ID: mdl-11754410
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Behcet Syndrome / Thrombophilia / Fibrinolytic Agents / Lipoproteins Type of study: Diagnostic_studies / Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Am J Hematol Year: 2001 Document type: Article Affiliation country: Turkey
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Behcet Syndrome / Thrombophilia / Fibrinolytic Agents / Lipoproteins Type of study: Diagnostic_studies / Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Am J Hematol Year: 2001 Document type: Article Affiliation country: Turkey